Provided by Tiger Trade Technology Pte. Ltd.

Oxford

25.38
-0.1000-0.39%
Post-market: 25.380.00000.00%19:30 EDT
Volume:382.83K
Turnover:9.71M
Market Cap:380.15M
PE:-55.21
High:25.73
Open:25.65
Low:24.92
Close:25.48
52wk High:49.58
52wk Low:24.20
Shares:14.98M
Float Shares:14.30M
Volume Ratio:0.60
T/O Rate:2.68%
Dividend:2.78
Dividend Rate:10.95%
EPS(TTM):-0.4597
EPS(LYR):-1.8639
ROE:-1.17%
ROA:0.98%
PB:0.67
PE(LYR):-13.62

Loading ...

Oxford Instruments Issues New Shares Under Employee Option Schemes

TIPRANKS
·
Jul 01

Oxford Nanopore Expands Share Capital Through Option Exercises and Remuneration Schemes

TIPRANKS
·
Jul 01

Oxford Biomedica Confirms 121 Million Voting Rights in Updated Share Capital

TIPRANKS
·
Jul 01

Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial

GlobeNewswire
·
Jun 29

Oxford Industries Shareholders Approve Directors and Incentive Plan

TIPRANKS
·
Jun 27

Oxford Industries Shareholders Approve Amended Long-term Stock Incentive Plan, Adding 750,000 Shares

Reuters
·
Jun 27

Oxford Instruments Tightens Share Base with Latest Buyback Tranche

TIPRANKS
·
Jun 26

Oxford Biomedica price target lowered to 1,140 GBp at RBC Capital

TIPRANKS
·
Jun 25

Oxford Instruments Publishes 2026 Annual Report and Schedules AGM

TIPRANKS
·
Jun 23

Oxford Biomedica Expands Share Capital with New Employee Scheme Allotments

TIPRANKS
·
Jun 22

Oxford Instruments Cuts Share Count Further Through Ongoing Buyback

TIPRANKS
·
Jun 19

Oxford Industries management to meet with KeyBanc

TIPRANKS
·
Jun 19

Oxford Metrics director boosts stake with share purchase

TIPRANKS
·
Jun 18

Kyle Mikson Reiterates Buy on Oxford Nanopore, Sees Differentiated Growth with Unchanged 200p Price Target

TIPRANKS
·
Jun 18

Oxford Metrics chair and associate lift stake with fresh share purchases

TIPRANKS
·
Jun 17

Oxford Biomedica Seeks LSE Admission for New Employee Incentive Shares

TIPRANKS
·
Jun 17

Oxford Metrics Sets Ambitious Growth and Margin Targets in Strategy Update

TIPRANKS
·
Jun 17

Oxford Industries Is Maintained at Neutral by Citigroup

Dow Jones
·
Jun 17

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

GlobeNewswire
·
Jun 16

Oxford Lane reports NAV per share of $11.40-$11.70 as of May 31

TIPRANKS
·
Jun 15